In SSc pulmonary and dermal tissues, levels of TLR4 and its damage-associated ligands are elevated, increasing sensitivity to TGFβ1 and enhancing the Smad pathway, fibroblast activation, and persistent fibrogenesis [100]. The gene discussed is TGFB1; the disease is systemic sclerosis.